ResearcherUniversity of TorontoNo recent work listed
Sadaf Aghevlian
Matched on OpenAlex author ID A5051836274. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2018: 1 paper · 2019: 1 paper · 2020: 1 paper
Papers 3
- Radioimmunotherapy of PANC-1 human pancreatic cancer xenografts in NOD/SCID or NRG mice with Panitumumab labeled with Auger electron emitting, 111In or β-parti… Co-author DOI 10.1186/s41181-020-00111-y↗
- Radioimmunotherapy of PANC-1 Human Pancreatic Cancer Xenografts in NRG Mice with Panitumumab Modified with Metal-Chelating Polymers Complexed to 177Lu. Co-author DOI 10.1021/acs.molpharmaceut.8b01040↗
- Panitumumab Modified with Metal-Chelating Polymers (MCP) Complexed to 111In and 177Lu-An EGFR-Targeted Theranostic for Pancreatic Cancer. Co-author DOI 10.1021/acs.molpharmaceut.7b01000↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- David William Hedley · 3 shared papers, 2018–2020 · strength 0.37
- Paper Radioimmunotherapy of PANC-1 human pancreatic cancer xenografts in NOD/SCID or NRG mice with Panitumumab labeled with A… DOI 10.1186/s41181-020-00111-y↗
- Paper Radioimmunotherapy of PANC-1 Human Pancreatic Cancer Xenografts in NRG Mice with Panitumumab Modified with Metal-Chelat… DOI 10.1021/acs.molpharmaceut.8b01040↗
- Paper Panitumumab Modified with Metal-Chelating Polymers (MCP) Complexed to 111In and 177Lu-An EGFR-Targeted Theranostic for … DOI 10.1021/acs.molpharmaceut.7b01000↗
- Mitchell A. Winnik · 3 shared papers, 2018–2020 · strength 0.37
- Paper Radioimmunotherapy of PANC-1 human pancreatic cancer xenografts in NOD/SCID or NRG mice with Panitumumab labeled with A… DOI 10.1186/s41181-020-00111-y↗
- Paper Radioimmunotherapy of PANC-1 Human Pancreatic Cancer Xenografts in NRG Mice with Panitumumab Modified with Metal-Chelat… DOI 10.1021/acs.molpharmaceut.8b01040↗
- Paper Panitumumab Modified with Metal-Chelating Polymers (MCP) Complexed to 111In and 177Lu-An EGFR-Targeted Theranostic for … DOI 10.1021/acs.molpharmaceut.7b01000↗
- Raymond M. Reilly · 3 shared papers, 2018–2020 · strength 0.37
- Paper Radioimmunotherapy of PANC-1 human pancreatic cancer xenografts in NOD/SCID or NRG mice with Panitumumab labeled with A… DOI 10.1186/s41181-020-00111-y↗
- Paper Radioimmunotherapy of PANC-1 Human Pancreatic Cancer Xenografts in NRG Mice with Panitumumab Modified with Metal-Chelat… DOI 10.1021/acs.molpharmaceut.8b01040↗
- Paper Panitumumab Modified with Metal-Chelating Polymers (MCP) Complexed to 111In and 177Lu-An EGFR-Targeted Theranostic for … DOI 10.1021/acs.molpharmaceut.7b01000↗
- Yijie Lu · 2 shared papers, 2018–2019 · strength 0.22
- Paper Radioimmunotherapy of PANC-1 Human Pancreatic Cancer Xenografts in NRG Mice with Panitumumab Modified with Metal-Chelat… DOI 10.1021/acs.molpharmaceut.8b01040↗
- Paper Panitumumab Modified with Metal-Chelating Polymers (MCP) Complexed to 111In and 177Lu-An EGFR-Targeted Theranostic for … DOI 10.1021/acs.molpharmaceut.7b01000↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.